Tema Heart & Health ETF (NASDAQ:HRTS) Sees Significant Increase in Short Interest

Tema Heart & Health ETF (NASDAQ:HRTS) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 5,095 shares, a growth of 797.0% from the July 15th total of 568 shares. Currently, 0.3% of the shares of the company are short sold. Based on an average daily volume of 9,385 shares, the short-interest ratio is presently 0.5 days.

Tema Heart & Health ETF Stock Down 0.2%

Shares of NASDAQ:HRTS traded down $0.07 during trading on Tuesday, reaching $37.72. 1,881 shares of the company traded hands, compared to its average volume of 6,243. The firm has a market capitalization of $56.20 million, a PE ratio of 22.06 and a beta of 0.63. Tema Heart & Health ETF has a 52 week low of $27.79 and a 52 week high of $37.79. The company’s 50 day moving average is $35.87 and its two-hundred day moving average is $34.94.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of HRTS. Citadel Advisors LLC acquired a new stake in shares of Tema Heart & Health ETF during the third quarter valued at about $243,000. Stifel Financial Corp raised its holdings in Tema Heart & Health ETF by 19.8% in the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after buying an additional 5,571 shares during the last quarter. Jane Street Group LLC raised its holdings in Tema Heart & Health ETF by 9.4% in the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after buying an additional 3,202 shares during the last quarter. JPMorgan Chase & Co. acquired a new stake in Tema Heart & Health ETF during the 2nd quarter worth approximately $63,000. Finally, Royal Bank of Canada grew its holdings in Tema Heart & Health ETF by 8.8% during the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after acquiring an additional 1,703 shares during the last quarter.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.